ELIZABETH CABEZON: Open Payments
NPI 1982624011 · FRESH MEADOWS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $111 |
| Astellas Pharma US Inc | 1 | $98 |
| Janssen Biotech, Inc. | 1 | $69 |
| Sumitomo Pharma America, Inc. | 1 | $62 |
| Boston Scientific Corporation | 1 | $24 |
Products named: KEYTRUDA, Xtandi, RYBREVANT, GEMTESA, General - Kidney Stone Disease.
Industry payments across NY — which companies pay providers there.
